Pathology and pathways of Alzheimer's disease with an update on new developments in treatment. (Q35151999)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12801388%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Pathology and pathways of Alzheimer's disease with an update on new developments in treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12801388%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12801388%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

Steven T DeKosky

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12801388%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Geriatrics Society

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12801388%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12801388%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

5 Suppl Dementia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12801388%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

S314-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12801388%20AND%20SRC:MED&resulttype=core&format=json

Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Alzheimer's disease: the problem of incorrect clinical diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Documentation and evaluation of cognitive impairment in elderly primary care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Measurement of functional activities in older adults in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Clinical trial of indomethacin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.5157.X

10.1046/J.1532-5415.5157.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12801388%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference